FDA Inspection 578807 — Eurofins Biopharma Product Testing, Denmark A/S

Eurofins Biopharma Product Testing, Denmark A/S — FEI 3006272083

The FDA completed an inspection of Eurofins Biopharma Product Testing, Denmark A/S on May 12, 2009 in Glostrup. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 12, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glostrup (Denmark)